Free Trial

JPMorgan Chase & Co. Has $7.63 Million Stake in Endava plc (NYSE:DAVA)

Endava logo with Computer and Technology background

JPMorgan Chase & Co. trimmed its stake in Endava plc (NYSE:DAVA - Free Report) by 14.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 298,704 shares of the company's stock after selling 49,592 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.51% of Endava worth $7,629,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in DAVA. Blue Trust Inc. bought a new position in shares of Endava in the third quarter valued at $30,000. Signaturefd LLC grew its position in shares of Endava by 84.1% in the 3rd quarter. Signaturefd LLC now owns 1,939 shares of the company's stock valued at $50,000 after acquiring an additional 886 shares during the period. Seven Eight Capital LP bought a new position in shares of Endava in the 2nd quarter valued at about $216,000. Precision Wealth Strategies LLC increased its stake in shares of Endava by 6.7% during the 3rd quarter. Precision Wealth Strategies LLC now owns 8,571 shares of the company's stock worth $219,000 after purchasing an additional 540 shares during the last quarter. Finally, Strengthening Families & Communities LLC raised its holdings in shares of Endava by 11.4% in the 3rd quarter. Strengthening Families & Communities LLC now owns 9,116 shares of the company's stock valued at $233,000 after purchasing an additional 933 shares during the period. Institutional investors and hedge funds own 62.23% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Needham & Company LLC boosted their price target on Endava from $36.00 to $43.00 and gave the stock a "buy" rating in a research report on Friday, January 10th. Bank of America started coverage on Endava in a report on Friday, November 22nd. They set a "neutral" rating and a $29.00 price target for the company. Susquehanna decreased their price objective on shares of Endava from $66.00 to $55.00 and set a "positive" rating on the stock in a report on Friday, September 20th. Citigroup dropped their price objective on shares of Endava from $30.00 to $27.00 and set a "neutral" rating on the stock in a research report on Monday, October 28th. Finally, TD Cowen lifted their target price on shares of Endava from $35.00 to $36.00 and gave the stock a "buy" rating in a report on Wednesday, November 13th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $40.46.

Get Our Latest Report on DAVA

Endava Stock Performance

Shares of NYSE:DAVA traded up $0.47 on Wednesday, reaching $31.57. 169,566 shares of the company's stock were exchanged, compared to its average volume of 374,681. The company has a current ratio of 1.90, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $1.86 billion, a price-to-earnings ratio of 225.50, a PEG ratio of 2.12 and a beta of 1.22. The company has a fifty day moving average of $29.47 and a 200-day moving average of $28.92. Endava plc has a twelve month low of $23.28 and a twelve month high of $81.06.

Endava Profile

(Free Report)

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

Featured Stories

Institutional Ownership by Quarter for Endava (NYSE:DAVA)

Should You Invest $1,000 in Endava Right Now?

Before you consider Endava, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.

While Endava currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines